Pharmaceuticals: Major
Major German companies producing pharmaceuticals
Global pharmaceutical corporations develop and distribute prescription medications at a massive scale. Patent expirations, pipeline approvals, and healthcare legislation serve as major catalysts for trading activity and industry liquidity. Market data indicates that Ocugen Inc is currently the highest-volume asset, while ImmunityBio Inc tops the 24-hour return list. The table below tracks the vital technical and fundamental metrics for these equities.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.19 T EUR | 1,225.8 EUR | +0.26% | 276 | 0.96 | 45.62 | 26.87 EUR | +55.94% | 0.47% | Health technology | Strong buy |
 JNJJohnson & Johnson | 592.45 B EUR | 244.25 EUR | −0.87% | 150 | 0.48 | 41.97 | 5.82 EUR | −34.10% | 1.91% | Health technology | Buy |
 4ABAbbVie, Inc. | 464.16 B EUR | 259.4 EUR | −0.04% | 57 | 0.52 | 50.57 | 5.13 EUR | +354.14% | 2.35% | Health technology | Buy |
 RHORoche Holding Ltd | 343.88 B EUR | 441.2 EUR | +1.05% | 60 | 0.86 | 26.58 | 16.60 EUR | +32.10% | 2.69% | Health technology | Buy |
 6MKMerck & Co., Inc. | 330.4 B EUR | 129.50 EUR | −2.22% | 0 | 0.00 | 149.82 | 0.86 EUR | −86.58% | 2.26% | Health technology | Buy |
 NOTNovartis AG | 267.8 B EUR | 145.20 EUR | +0.14% | 612 | 0.50 | 33.14 | 4.38 EUR | −33.91% | 2.76% | Health technology | Neutral |
 NOVNovo Nordisk A/S Class B | 168.68 B EUR | 36.100 EUR | +1.01% | 6.33 K | 0.44 | 10.62 | 3.40 EUR | +9.26% | 4.10% | Health technology | Neutral |
 PFEPfizer Inc. | 156.31 B EUR | 26.325 EUR | −2.63% | 3.29 K | 0.47 | 42.65 | 0.62 EUR | −57.78% | 5.59% | Health technology | Neutral |
 VX1Vertex Pharmaceuticals Incorporated | 123.98 B EUR | 481.10 EUR | −1.58% | 14 | 0.21 | 35.06 | 13.72 EUR | +13.49% | 0.00% | Health technology | Buy |
 BRMBristol-Myers Squibb Company | 116.86 B EUR | 55.51 EUR | −3.86% | 570 | 2.21 | 13.93 | 3.98 EUR | +57.85% | 3.93% | Health technology | Buy |
 SNWSanofi SA | 100.88 B EUR | 82.50 EUR | −1.59% | 1.09 K | 0.62 | 24.78 | 3.33 EUR | −35.60% | 4.90% | Health technology | Buy |
 GS71GSK plc | 90.87 B EUR | 22.46 EUR | −1.62% | 1.32 K | 3.47 | 17.97 | 1.25 EUR | −18.22% | 3.60% | Health technology | Neutral |
 RGORegeneron Pharmaceuticals, Inc. | 85.73 B EUR | 814.4 EUR | −1.88% | 0 | 0.00 | 20.37 | 39.99 EUR | +12.33% | 0.40% | Health technology | Buy |
 MRKMerck KGaA | 65.41 B EUR | 147.80 EUR | −0.27% | 141 | 0.10 | 27.11 | 5.45 EUR | −17.22% | 1.46% | Health technology | Buy |
 CUPChugai Pharmaceutical Co., Ltd. | 63.77 B EUR | 38.40 EUR | −4.00% | 0 | 0.00 | 22.37 | 1.72 EUR | +23.47% | 3.09% | Health technology | Buy |
 TKDTakeda Pharmaceutical Co. Ltd. | 59.1 B EUR | 37.06 EUR | −3.29% | 0 | 0.00 | 315.22 | 0.12 EUR | +2.11% | 3.07% | Health technology | Buy |
 UNCUCB S.A. | 53.69 B EUR | 288.0 EUR | −0.35% | 0 | 0.00 | 25.47 | 11.31 EUR | +64.98% | 0.36% | Health technology | Buy |
 BAYNBayer AG | 53.29 B EUR | 55.10 EUR | −0.83% | 26.01 K | 1.85 | — | −1.77 EUR | +49.15% | 0.20% | Health technology | Buy |
 PY3Galderma Group AG | 49.43 B EUR | 206 EUR | −1.90% | 0 | 0.00 | 65.49 | 3.15 EUR | +113.32% | 0.18% | Health technology | Buy |
 D8YSandoz Group Ltd | 39.38 B EUR | 90.82 EUR | +1.29% | 0 | 0.00 | 71.22 | 1.28 EUR | +169.78% | 0.97% | Health technology | Neutral |
 H6D0Haleon PLC | 35.59 B EUR | 3.943 EUR | −2.62% | 0 | 0.00 | 18.75 | 0.21 EUR | +7.95% | 2.16% | Health technology | Buy |
 OS1Otsuka Holdings Co., Ltd. | 35.13 B EUR | 67.0 EUR | −1.47% | 0 | 0.00 | 16.23 | 4.13 EUR | −14.96% | 1.43% | Health technology | Buy |
 RPDRoyalty Pharma Plc Class A | 34.68 B EUR | 59.05 EUR | −2.17% | 0 | — | 43.53 | 1.36 EUR | −8.97% | 1.37% | Health technology | Buy |
 IDPBiogen Inc. | 33.5 B EUR | 217.15 EUR | −3.81% | 0 | 0.00 | 105.31 | 2.06 EUR | −77.93% | 0.00% | Health technology | Buy |
 ZOEZoetis, Inc. Class A | 32.83 B EUR | 71.18 EUR | −2.20% | 188 | 0.81 | 13.37 | 5.32 EUR | +7.88% | 2.38% | Health technology | Neutral |
 D4SDaiichi Sankyo Company, Limited | 29.75 B EUR | 15.896 EUR | −9.79% | 100 | 0.13 | 17.31 | 0.92 EUR | +6.60% | 3.06% | Health technology | Buy |
 YPHAstellas Pharma Inc. | 25.31 B EUR | 14.1 EUR | −4.08% | 0 | 0.00 | 11.72 | 1.20 EUR | +201.15% | 3.16% | Health technology | Neutral |
 ICYIncyte Corporation | 22.3 B EUR | 105.60 EUR | −2.72% | 122 | 8.71 | 63.66 | 1.66 EUR | −67.34% | 0.00% | Health technology | Buy |
 IM8NInsmed Incorporated | 21.49 B EUR | 96.25 EUR | −2.54% | 0 | 0.00 | — | −2.49 EUR | +52.81% | 0.00% | Health technology | Strong buy |
 VIAViatris, Inc. | 19.66 B EUR | 17.664 EUR | +1.63% | 1.52 K | 1.16 | — | −0.31 EUR | +87.33% | 2.50% | Health technology | Buy |
 DULAlnylam Pharmaceuticals, Inc | 19.22 B EUR | 140.40 EUR | +0.43% | 244 | 7.28 | 8.03 | 17.48 EUR | +8,430.94% | 0.00% | Health technology | Buy |
 SH0Shionogi & Co., Ltd. | 14.97 B EUR | 16.475 EUR | −3.82% | 675 | 8.77 | 10.37 | 1.59 EUR | +37.38% | 2.58% | Health technology | Buy |
 J7ZJazz Pharmaceuticals Public Limited Company | 13.42 B EUR | 210.4 EUR | +3.80% | 20 | 3.28 | 80.85 | 2.60 EUR | — | 0.00% | Health technology | Strong buy |
 RGNRepligen Corporation | 10.15 B EUR | 155.00 EUR | +2.55% | 0 | 0.00 | — | −0.18 EUR | −944.39% | 0.00% | Health technology | Buy |
 26CAImmunityBio Inc | 8.43 B EUR | 7.77 EUR | +8.37% | 0 | 0.00 | — | −0.85 EUR | −102.74% | 0.00% | Health technology | Strong buy |
 3920Spyre Therapeutics, Inc | 8.38 B EUR | 85.5 EUR | −1.16% | 0 | — | — | −2.72 EUR | −46.63% | 0.00% | Health technology | Strong buy |
 YDO1Madrigal Pharmaceuticals, Inc. | 8.28 B EUR | 355.5 EUR | −0.28% | 0 | 0.00 | — | −5.28 EUR | +52.41% | 0.00% | Health technology | Strong buy |
 KK3ACytokinetics, Incorporated | 7.88 B EUR | 47.99 EUR | −3.89% | 0 | 0.00 | — | −6.32 EUR | −45.47% | 0.00% | Health technology | Strong buy |
 KY4Kyowa Kirin Co., Ltd. | 7.26 B EUR | 13.7 EUR | −6.16% | 0 | 0.00 | 14.85 | 0.92 EUR | +129.23% | 2.71% | Health technology | Sell |
 4AJ0ALK-abello A/S Class B | 7.24 B EUR | 32.62 EUR | +0.06% | 0 | 0.00 | 39.96 | 0.82 EUR | +35.40% | 0.66% | Health technology | Strong buy |
 LDBBH. Lundbeck A/S Class A | 7.13 B EUR | 6.72 EUR | −1.18% | 0 | — | 12.88 | 0.52 EUR | +11.06% | 2.27% | Health technology | No rating |
 8AKAlkermes Public Limited Company | 6.87 B EUR | 40.50 EUR | +1.38% | 0 | 0.00 | — | −0.01 EUR | −100.70% | 0.00% | Health technology | Buy |
 1RVRhythm Pharmaceuticals, Inc. | 6.83 B EUR | 89.5 EUR | −1.65% | 0 | 0.00 | — | −2.57 EUR | +2.77% | 0.00% | Health technology | Strong buy |
 OZTAGrifols, S.A. Class A | 6.67 B EUR | 11.055 EUR | −1.34% | 0 | 0.00 | 16.63 | 0.66 EUR | +51.93% | 1.68% | Health technology | Buy |
 ON4ONO Pharmaceutical Co., Ltd. | 6.28 B EUR | 12.745 EUR | −4.75% | 0 | — | 14.33 | 0.89 EUR | +49.68% | 3.36% | Health technology | Neutral |
 HQ1Oruka Therapeutics, Inc. | 5.98 B EUR | 87.0 EUR | −2.79% | 50 | 1.95 | — | −2.16 EUR | +30.14% | 0.00% | Health technology | Strong buy |
 ISIIonis Pharmaceuticals, Inc. | 5.94 B EUR | 34.36 EUR | −2.75% | 0 | — | — | −3.04 EUR | −93.45% | 0.00% | Health technology | Strong buy |
 08DMirum Pharmaceuticals, Inc. | 5.64 B EUR | 81.94 EUR | −3.28% | 0 | 0.00 | — | −13.44 EUR | −1,729.40% | 0.00% | Health technology | Strong buy |
 E7PSupernus, Inc. | 5.22 B EUR | 23.2 EUR | −5.69% | 2 | 0.07 | 7.27 | 3.19 EUR | +272.58% | 0.00% | Health technology | Strong buy |
 BH3PTC Therapeutics, Inc. | 5.13 B EUR | 58.58 EUR | −0.20% | 0 | — | — | −1.24 EUR | −117.05% | 0.00% | Health technology | Buy |
 LT4Liquidia Corporation | 3.78 B EUR | 39.54 EUR | −5.36% | 0 | 0.00 | 33.10 | 1.19 EUR | — | 0.00% | Health technology | Buy |
 SZDSanten Pharmaceutical Co., Ltd. | 3.24 B EUR | 10.9 EUR | +4.81% | 63 | — | 17.04 | 0.64 EUR | +18.75% | 2.23% | Health technology | Buy |
 7XPOrganon & Co. | 3.23 B EUR | 12.405 EUR | +0.89% | 0 | 0.00 | 18.28 | 0.68 EUR | −58.61% | 0.58% | Health technology | Neutral |
 41LLaboratorios Farmaceuticos Rovi, S.A. | 3.22 B EUR | 67.00 EUR | −1.69% | 29 | 2.90 | 18.51 | 3.62 EUR | +39.34% | 1.22% | Health technology | Buy |
 LP6Livzon Pharmaceutical Group Inc Class H | 3.22 B EUR | 2.68 EUR | +2.29% | 0 | — | 11.96 | 0.22 EUR | −21.11% | 6.82% | Health technology | Buy |
 1VTViking Therapeutics, Inc. | 3.18 B EUR | 23.75 EUR | +3.26% | 0 | 0.00 | — | −4.77 EUR | −164.35% | 0.00% | Health technology | Strong buy |
 PIGPerrigo Co. Plc | 1.96 B EUR | 14.105 EUR | +1.51% | 0 | 0.00 | — | −11.27 EUR | −3,409.18% | 7.33% | Health technology | Neutral |
 DMPDermapharm Holding SE | 1.93 B EUR | 37.80 EUR | −2.95% | 0 | 0.00 | 13.70 | 2.76 EUR | +38.58% | 2.26% | Health technology | Buy |
 3JRSopharma AD | 1.68 B EUR | 3.25 EUR | +1.56% | 0 | 0.00 | 21.75 | 0.15 EUR | +52.60% | 2.97% | Health technology | No rating |
 RXK3SELLAS Life Sciences Group, Inc. | 1.64 B EUR | 6.42 EUR | −13.94% | 200 | 0.35 | — | −0.19 EUR | +33.35% | 0.00% | Health technology | Strong buy |
 TSUATsumura & Co. | 1.64 B EUR | 21.0 EUR | 0.00% | 0 | 0.00 | 9.62 | 2.18 EUR | +9.65% | 4.15% | Health technology | Neutral |
 UP0Ultragenyx Pharmaceutical, Inc. | 1.51 B EUR | 13.535 EUR | −10.42% | 0 | — | — | −4.58 EUR | +9.50% | 0.00% | Health technology | Buy |
 5NRNanobiotix SA | 1.37 B EUR | 26.10 EUR | −3.33% | 0 | — | — | −1.09 EUR | −47.23% | 0.00% | Health technology | Strong buy |
 19TIdorsia Ltd. | 1.29 B EUR | 4.418 EUR | −8.00% | 0 | 0.00 | — | −1.17 EUR | −64.15% | 0.00% | Health technology | Neutral |
 ITH0Nektar Therapeutics | 1.17 B EUR | 31.73 EUR | −5.42% | 0 | 0.00 | — | −5.86 EUR | +20.77% | 0.00% | Health technology | Buy |
 C43Cosmo N.V. | 1.1 B EUR | 61.2 EUR | −6.71% | 50 | 1.40 | — | −0.38 EUR | −111.41% | 3.22% | Health technology | Strong buy |
 PK5Basilea Pharmaceutica AG | 988.59 M EUR | 76.1 EUR | −4.88% | 0 | 0.00 | 18.00 | 4.23 EUR | −26.19% | 0.00% | Health technology | Buy |
 6QCTowa Pharmaceutical Co., Ltd. | 972.2 M EUR | 18.3 EUR | −9.41% | 0 | — | 20.24 | 0.90 EUR | −52.78% | 2.28% | Health technology | Strong buy |
 4A3Immatics N.V. | 920.92 M EUR | 5.450 EUR | −0.91% | 0 | 0.00 | — | −1.62 EUR | −173.03% | 0.00% | Health technology | Strong buy |
 PHGNPharming Group NV | 784.58 M EUR | 1.0870 EUR | −0.96% | 0 | — | 39.53 | 0.03 EUR | — | 0.00% | Health technology | Strong buy |
 MFYMochida Pharmaceutical Co., Ltd. | 626.32 M EUR | 17.6 EUR | −6.38% | 0 | — | 12.61 | 1.40 EUR | +39.43% | 2.52% | Health technology | No rating |
 DBVDBV Technologies SA | 554.48 M EUR | 1.724 EUR | +4.36% | 0 | 0.00 | — | −0.52 EUR | +45.11% | 0.00% | Health technology | Strong buy |
 4LN2Capricor Therapeutics, Inc. | 461.89 M EUR | 7.610 EUR | −0.50% | 0 | 0.00 | — | −2.14 EUR | −53.97% | 0.00% | Health technology | Buy |
 JCRJCR Pharmaceuticals Co., Ltd. | 350.52 M EUR | 2.72 EUR | −6.85% | 0 | — | — | −0.16 EUR | −63.03% | 3.97% | Health technology | Buy |
 FYBFormycon AG | 330.13 M EUR | 13.82 EUR | −4.03% | 183 | 0.32 | — | −1.42 EUR | +85.20% | 0.00% | Health technology | Strong buy |
 2H51Ocugen Inc | 264.13 M EUR | 0.819 EUR | +6.36% | 40.74 K | 5.36 | — | −0.18 EUR | +4.73% | 0.00% | Health technology | Strong buy |
 25EElan Corp. | 252.46 M EUR | 4.04 EUR | −3.35% | 0 | — | 12.46 | 0.32 EUR | +33.73% | 2.02% | Health technology | No rating |
 NP5Newron Pharmaceuticals S.p.A. | 217.54 M EUR | 9.44 EUR | +1.29% | 0 | 0.00 | — | −1.46 EUR | −213.88% | 0.00% | Health technology | Buy |
 IMRAC Immune SA | 207.58 M EUR | 1.942 EUR | +5.54% | 0 | 0.00 | — | −0.49 EUR | +1.58% | 0.00% | Health technology | Strong buy |
 IDDInnate Pharma SA Class A | 140.07 M EUR | 1.226 EUR | +0.82% | 0 | — | — | −0.51 EUR | +7.91% | 0.00% | Health technology | Strong buy |
 41OOutlook Therapeutics, Inc. | 100.2 M EUR | 0.3748 EUR | −6.63% | 0 | 0.00 | — | — | — | 0.00% | Health technology | Strong buy |
 HPHAHeidelberg Pharma AG | 94.04 M EUR | 2.090 EUR | +4.50% | 0 | 0.00 | — | −0.64 EUR | −13.94% | 0.00% | Health technology | Strong buy |
 PTPPentixapharm Holding AG | 67.66 M EUR | 1.835 EUR | −5.41% | 0 | 0.00 | — | — | — | 0.00% | Health technology | Strong buy |
 PV3BEyePoint, Inc. | 30.33 M EUR | 0.312 EUR | −5.45% | 0 | 0.00 | — | −3.28 EUR | −44.18% | 0.00% | Health technology | Neutral |
 B8FKBiofrontera AG | 17.74 M EUR | 2.91 EUR | +3.19% | 0 | 0.00 | — | — | — | 0.00% | Health technology | No rating |
 27N0CANNOVUM CANNABIS AG | 1.08 M EUR | 0.438 EUR | +5.80% | 0 | 0.00 | — | — | — | — | Health technology | No rating |